img

Global and United States Rabies Immune Globulin (Equine) Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Rabies Immune Globulin (Equine) Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Rabies Immune Globulin (Equine) Market
This report focuses on global and United States Rabies Immune Globulin (Equine) market, also covers the segmentation data of other regions in regional level and county level.
The global Rabies Immune Globulin (Equine) revenue was US$ 1200 million in 2022 and is forecast to a readjusted size of US$ 1526.7 million by 2034 with a CAGR of 3.5% during the forecast period (2024-2034).
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.

The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
Global Rabies Immune Globulin (Equine) Scope and Market Size
Rabies Immune Globulin (Equine) market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Rabies Immune Globulin (Equine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2024-2034.
For United States market, this report focuses on the Rabies Immune Globulin (Equine) market size by players, by Type and by Application, for the period 2024-2034. The key players include the global and local players, which play important roles in United States.



By Company


Grifols
Serum China
Premium Serums
Intas
Aventis Pasteur India
Cadila Pharmaceuticals
Zydus Takeda Healthcare
Bharat Serums And Vaccines
GlaxoSmithKline GmbH
VINS Bioproducts
CSL Behring
Segment by Type
1500IU
1000IU
400IU
Others

Segment by Application


Clinic
Hospital
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Rabies Immune Globulin (Equine) definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Rabies Immune Globulin (Equine) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Rabies Immune Globulin (Equine) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rabies Immune Globulin (Equine) sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Rabies Immune Globulin (Equine) Product Introduction
1.2 Global Rabies Immune Globulin (Equine) Outlook 2024 VS 2022 VS 2034
1.2.1 Global Rabies Immune Globulin (Equine) Sales in US$ Million for the Year 2024-2034
1.2.2 Global Rabies Immune Globulin (Equine) Sales in Volume for the Year 2024-2034
1.3 United States Rabies Immune Globulin (Equine) Outlook 2024 VS 2022 VS 2034
1.3.1 United States Rabies Immune Globulin (Equine) Sales in US$ Million for the Year 2024-2034
1.3.2 United States Rabies Immune Globulin (Equine) Sales in Volume for the Year 2024-2034
1.4 Rabies Immune Globulin (Equine) Market Size, United States VS Global, 2024 VS 2022 VS 2034
1.4.1 The Market Share of United States Rabies Immune Globulin (Equine) in Global, 2024 VS 2022 VS 2034
1.4.2 The Growth Rate of Rabies Immune Globulin (Equine) Market Size, United States VS Global, 2024 VS 2022 VS 2034
1.5 Rabies Immune Globulin (Equine) Market Dynamics
1.5.1 Rabies Immune Globulin (Equine) Industry Trends
1.5.2 Rabies Immune Globulin (Equine) Market Drivers
1.5.3 Rabies Immune Globulin (Equine) Market Challenges
1.5.4 Rabies Immune Globulin (Equine) Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Rabies Immune Globulin (Equine) by Type
2.1 Rabies Immune Globulin (Equine) Market Segment by Type
2.1.1 1500IU
2.1.2 1000IU
2.1.3 400IU
2.1.4 Others
2.2 Global Rabies Immune Globulin (Equine) Market Size by Type
2.2.1 Global Rabies Immune Globulin (Equine) Sales in Value, by Type (2024, 2022 & 2034)
2.2.2 Global Rabies Immune Globulin (Equine) Sales in Volume, by Type (2024, 2022 & 2034)
2.2.3 Global Rabies Immune Globulin (Equine) Average Selling Price (ASP) by Type (2024, 2022 & 2034)
2.3 United States Rabies Immune Globulin (Equine) Market Size by Type
2.3.1 United States Rabies Immune Globulin (Equine) Sales in Value, by Type (2024, 2022 & 2034)
2.3.2 United States Rabies Immune Globulin (Equine) Sales in Volume, by Type (2024, 2022 & 2034)
2.3.3 United States Rabies Immune Globulin (Equine) Average Selling Price (ASP) by Type (2024, 2022 & 2034)
3 Rabies Immune Globulin (Equine) by Application
3.1 Rabies Immune Globulin (Equine) Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.2 Global Rabies Immune Globulin (Equine) Market Size by Application
3.2.1 Global Rabies Immune Globulin (Equine) Sales in Value, by Application (2024, 2022 & 2034)
3.2.2 Global Rabies Immune Globulin (Equine) Sales in Volume, by Application (2024, 2022 & 2034)
3.3.3 Global Rabies Immune Globulin (Equine) Average Selling Price (ASP) by Application (2024, 2022 & 2034)
3.3 United States Rabies Immune Globulin (Equine) Market Size by Application
3.3.1 United States Rabies Immune Globulin (Equine) Sales in Value, by Application (2024, 2022 & 2034)
3.3.2 United States Rabies Immune Globulin (Equine) Sales in Volume, by Application (2024, 2022 & 2034)
3.3.3 United States Rabies Immune Globulin (Equine) Average Selling Price (ASP) by Application (2024, 2022 & 2034)
4 Global Rabies Immune Globulin (Equine) Competitor Landscape by Company
4.1 Global Rabies Immune Globulin (Equine) Market Size by Company
4.1.1 Global Key Manufacturers of Rabies Immune Globulin (Equine), Ranked by Revenue (2022)
4.1.2 Global Rabies Immune Globulin (Equine) Revenue by Manufacturer (2024-2024)
4.1.3 Global Rabies Immune Globulin (Equine) Sales by Manufacturer (2024-2024)
4.1.4 Global Rabies Immune Globulin (Equine) Price by Manufacturer (2024-2024)
4.2 Global Rabies Immune Globulin (Equine) Concentration Ratio (CR)
4.2.1 Rabies Immune Globulin (Equine) Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rabies Immune Globulin (Equine) in 2022
4.2.3 Global Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Rabies Immune Globulin (Equine), Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Rabies Immune Globulin (Equine), Product Offered and Application
4.5 Global Key Manufacturers of Rabies Immune Globulin (Equine), Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Rabies Immune Globulin (Equine) Market Size by Company
4.7.1 Key Players of Rabies Immune Globulin (Equine) in United States, Ranked by Revenue (2022)
4.7.2 United States Rabies Immune Globulin (Equine) Revenue by Players (2024-2024)
4.7.3 United States Rabies Immune Globulin (Equine) Sales by Players (2024-2024)
5 Global Rabies Immune Globulin (Equine) Market Size by Region
5.1 Global Rabies Immune Globulin (Equine) Market Size by Region: 2024 VS 2022 VS 2034
5.2 Global Rabies Immune Globulin (Equine) Market Size in Volume by Region (2024-2034)
5.2.1 Global Rabies Immune Globulin (Equine) Sales in Volume by Region: 2024-2024
5.2.2 Global Rabies Immune Globulin (Equine) Sales in Volume Forecast by Region (2024-2034)
5.3 Global Rabies Immune Globulin (Equine) Market Size in Value by Region (2024-2034)
5.3.1 Global Rabies Immune Globulin (Equine) Sales in Value by Region: 2024-2024
5.3.2 Global Rabies Immune Globulin (Equine) Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Rabies Immune Globulin (Equine) Market Size YoY Growth 2024-2034
6.2 Americas Rabies Immune Globulin (Equine) Sales in Volume, by Type (2024, 2022 & 2034)
6.3 Americas Rabies Immune Globulin (Equine) Sales in Volume, by Application (2024, 2022 & 2034)
6.4 Americas Rabies Immune Globulin (Equine) Market Facts & Figures by Country (2024, 2022 & 2034)
6.4.1 Americas Rabies Immune Globulin (Equine) Sales in Value by Country (2024, 2022 & 2034)
6.4.2 Americas Rabies Immune Globulin (Equine) Sales in Volume by Country (2024, 2022 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Rabies Immune Globulin (Equine) Market Size YoY Growth 2024-2034
7.2 EMEA Rabies Immune Globulin (Equine) Sales in Volume, by Type (2024, 2022 & 2034)
7.3 EMEA Rabies Immune Globulin (Equine) Sales in Volume, by Application (2024, 2022 & 2034)
7.4 EMEA Rabies Immune Globulin (Equine) Market Facts & Figures by Country (2024, 2022 & 2034)
7.4.1 EMEA Rabies Immune Globulin (Equine) Sales in Value by Country (2024, 2022 & 2034)
7.4.2 EMEA Rabies Immune Globulin (Equine) Sales in Volume by Country (2024, 2022 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Rabies Immune Globulin (Equine) Market Size YoY Growth 2024-2034
8.2 China Rabies Immune Globulin (Equine) Sales in Volume, by Type (2024, 2022 & 2034)
8.3 China Rabies Immune Globulin (Equine) Sales in Volume, by Application (2024, 2022 & 2034)
9 APAC
9.1 APAC Rabies Immune Globulin (Equine) Market Size YoY Growth 2024-2034
9.2 APAC Rabies Immune Globulin (Equine) Sales in Volume, by Type (2024, 2022 & 2034)
9.3 APAC Rabies Immune Globulin (Equine) Sales in Volume, by Application (2024, 2022 & 2034)
9.4 APAC Rabies Immune Globulin (Equine) Market Facts & Figures by Region (2024, 2022 & 2034)
9.4.1 APAC Rabies Immune Globulin (Equine) Sales in Value by Region (2024, 2022 & 2034)
9.4.2 APAC Rabies Immune Globulin (Equine) Sales in Volume by Region (2024, 2022 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Grifols
10.1.1 Grifols Company Information
10.1.2 Grifols Description and Business Overview
10.1.3 Grifols Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Grifols Rabies Immune Globulin (Equine) Products Offered
10.1.5 Grifols Recent Development
10.2 Serum China
10.2.1 Serum China Company Information
10.2.2 Serum China Description and Business Overview
10.2.3 Serum China Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Serum China Rabies Immune Globulin (Equine) Products Offered
10.2.5 Serum China Recent Development
10.3 Premium Serums
10.3.1 Premium Serums Company Information
10.3.2 Premium Serums Description and Business Overview
10.3.3 Premium Serums Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Premium Serums Rabies Immune Globulin (Equine) Products Offered
10.3.5 Premium Serums Recent Development
10.4 Intas
10.4.1 Intas Company Information
10.4.2 Intas Description and Business Overview
10.4.3 Intas Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Intas Rabies Immune Globulin (Equine) Products Offered
10.4.5 Intas Recent Development
10.5 Aventis Pasteur India
10.5.1 Aventis Pasteur India Company Information
10.5.2 Aventis Pasteur India Description and Business Overview
10.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Aventis Pasteur India Rabies Immune Globulin (Equine) Products Offered
10.5.5 Aventis Pasteur India Recent Development
10.6 Cadila Pharmaceuticals
10.6.1 Cadila Pharmaceuticals Company Information
10.6.2 Cadila Pharmaceuticals Description and Business Overview
10.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Products Offered
10.6.5 Cadila Pharmaceuticals Recent Development
10.7 Zydus Takeda Healthcare
10.7.1 Zydus Takeda Healthcare Company Information
10.7.2 Zydus Takeda Healthcare Description and Business Overview
10.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Products Offered
10.7.5 Zydus Takeda Healthcare Recent Development
10.8 Bharat Serums And Vaccines
10.8.1 Bharat Serums And Vaccines Company Information
10.8.2 Bharat Serums And Vaccines Description and Business Overview
10.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Products Offered
10.8.5 Bharat Serums And Vaccines Recent Development
10.9 GlaxoSmithKline GmbH
10.9.1 GlaxoSmithKline GmbH Company Information
10.9.2 GlaxoSmithKline GmbH Description and Business Overview
10.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.9.4 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Products Offered
10.9.5 GlaxoSmithKline GmbH Recent Development
10.10 VINS Bioproducts
10.10.1 VINS Bioproducts Company Information
10.10.2 VINS Bioproducts Description and Business Overview
10.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.10.4 VINS Bioproducts Rabies Immune Globulin (Equine) Products Offered
10.10.5 VINS Bioproducts Recent Development
10.11 CSL Behring
10.11.1 CSL Behring Company Information
10.11.2 CSL Behring Description and Business Overview
10.11.3 CSL Behring Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2024-2024)
10.11.4 CSL Behring Rabies Immune Globulin (Equine) Products Offered
10.11.5 CSL Behring Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Rabies Immune Globulin (Equine) Industry Chain Analysis
11.2 Rabies Immune Globulin (Equine) Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Rabies Immune Globulin (Equine) Production Mode & Process
11.4 Rabies Immune Globulin (Equine) Sales and Marketing
11.4.1 Rabies Immune Globulin (Equine) Sales Channels
11.4.2 Rabies Immune Globulin (Equine) Distributors
11.5 Rabies Immune Globulin (Equine) Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Rabies Immune Globulin (Equine) CAGR in Value, United States VS Global, 2024 VS 2022 VS 2034
Table 2. Rabies Immune Globulin (Equine) Market Trends
Table 3. Rabies Immune Globulin (Equine) Market Drivers
Table 4. Rabies Immune Globulin (Equine) Market Challenges
Table 5. Rabies Immune Globulin (Equine) Market Restraints
Table 6. Global Rabies Immune Globulin (Equine) Sales Growth Rate (CAGR) by Type: 2024 VS 2022 VS 2034 (US$ Million)
Table 7. United States Rabies Immune Globulin (Equine) Sales Growth Rate (CAGR) by Type: 2024 VS 2022 VS 2034 (US$ Million)
Table 8. Global Rabies Immune Globulin (Equine) Sales Growth Rate (CAGR) by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 9. United States Rabies Immune Globulin (Equine) Sales Growth Rate (CAGR) by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Rabies Immune Globulin (Equine), Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Rabies Immune Globulin (Equine) Revenue by Manufacturer, (US$ Million), 2024-2024
Table 12. Global Rabies Immune Globulin (Equine) Revenue Share by Manufacturer, 2024-2024
Table 13. Global Rabies Immune Globulin (Equine) Sales by Manufacturer, (K Units), 2024-2024
Table 14. Global Rabies Immune Globulin (Equine) Sales Share by Manufacturer, 2024-2024
Table 15. Global Rabies Immune Globulin (Equine) Price by Manufacturer (2024-2024) & (US$/Unit)
Table 16. Global Rabies Immune Globulin (Equine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Rabies Immune Globulin (Equine) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Equine) as of 2022)
Table 18. Global Key Manufacturers of Rabies Immune Globulin (Equine), Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Rabies Immune Globulin (Equine), Product Offered and Application
Table 20. Global Key Manufacturers of Rabies Immune Globulin (Equine), Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Rabies Immune Globulin (Equine) in United States, Ranked by Revenue (2022) & (US$ million)
Table 23. United States Rabies Immune Globulin (Equine) Revenue by Players, (US$ Million), (2024-2024)
Table 24. United States Rabies Immune Globulin (Equine) Revenue Share by Players, (2024-2024)
Table 25. United States Rabies Immune Globulin (Equine) Sales by Players, (K Units), (2024-2024)
Table 26. United States Rabies Immune Globulin (Equine) Sales Share by Players, (2024-2024)
Table 27. Global Rabies Immune Globulin (Equine) Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 28. Global Rabies Immune Globulin (Equine) Sales in Volume by Region (2024-2024) & (K Units)
Table 29. Global Rabies Immune Globulin (Equine) Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Rabies Immune Globulin (Equine) Sales in Value by Region (2024-2024) & (US$ Million)
Table 31. Global Rabies Immune Globulin (Equine) Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Rabies Immune Globulin (Equine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2024 VS 2022 VS 2034
Table 33. Americas Rabies Immune Globulin (Equine) Sales in Value by Country (2024-2024) & (US$ Million)
Table 34. Americas Rabies Immune Globulin (Equine) Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Rabies Immune Globulin (Equine) Sales in Volume by Country (2024-2024) & (K Units)
Table 36. Americas Rabies Immune Globulin (Equine) Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Rabies Immune Globulin (Equine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2024 VS 2022 VS 2034
Table 38. EMEA Rabies Immune Globulin (Equine) Sales in Value by Country (2024-2024) & (US$ Million)
Table 39. EMEA Rabies Immune Globulin (Equine) Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Rabies Immune Globulin (Equine) Sales in Volume by Country (2024-2024) & (K Units)
Table 41. EMEA Rabies Immune Globulin (Equine) Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Rabies Immune Globulin (Equine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2024 VS 2022 VS 2034
Table 43. APAC Rabies Immune Globulin (Equine) Sales in Value by Country (2024-2024) & (US$ Million)
Table 44. APAC Rabies Immune Globulin (Equine) Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Rabies Immune Globulin (Equine) Sales in Volume by Country (2024-2024) & (K Units)
Table 46. APAC Rabies Immune Globulin (Equine) Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Grifols Company Information
Table 48. Grifols Description and Business Overview
Table 49. Grifols Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 50. Grifols Rabies Immune Globulin (Equine) Product
Table 51. Grifols Recent Development
Table 52. Serum China Company Information
Table 53. Serum China Description and Business Overview
Table 54. Serum China Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 55. Serum China Rabies Immune Globulin (Equine) Product
Table 56. Serum China Recent Development
Table 57. Premium Serums Company Information
Table 58. Premium Serums Description and Business Overview
Table 59. Premium Serums Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 60. Premium Serums Rabies Immune Globulin (Equine) Product
Table 61. Premium Serums Recent Development
Table 62. Intas Company Information
Table 63. Intas Description and Business Overview
Table 64. Intas Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 65. Intas Rabies Immune Globulin (Equine) Product
Table 66. Intas Recent Development
Table 67. Aventis Pasteur India Company Information
Table 68. Aventis Pasteur India Description and Business Overview
Table 69. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 70. Aventis Pasteur India Rabies Immune Globulin (Equine) Product
Table 71. Aventis Pasteur India Recent Development
Table 72. Cadila Pharmaceuticals Company Information
Table 73. Cadila Pharmaceuticals Description and Business Overview
Table 74. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 75. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product
Table 76. Cadila Pharmaceuticals Recent Development
Table 77. Zydus Takeda Healthcare Company Information
Table 78. Zydus Takeda Healthcare Description and Business Overview
Table 79. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 80. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product
Table 81. Zydus Takeda Healthcare Recent Development
Table 82. Bharat Serums And Vaccines Company Information
Table 83. Bharat Serums And Vaccines Description and Business Overview
Table 84. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 85. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product
Table 86. Bharat Serums And Vaccines Recent Development
Table 87. GlaxoSmithKline GmbH Company Information
Table 88. GlaxoSmithKline GmbH Description and Business Overview
Table 89. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 90. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product
Table 91. GlaxoSmithKline GmbH Recent Development
Table 92. VINS Bioproducts Company Information
Table 93. VINS Bioproducts Description and Business Overview
Table 94. VINS Bioproducts Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 95. VINS Bioproducts Rabies Immune Globulin (Equine) Product
Table 96. VINS Bioproducts Recent Development
Table 97. CSL Behring Company Information
Table 98. CSL Behring Description and Business Overview
Table 99. CSL Behring Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 100. CSL Behring Rabies Immune Globulin (Equine) Product
Table 101. CSL Behring Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Rabies Immune Globulin (Equine) Customers List
Table 105. Rabies Immune Globulin (Equine) Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Immune Globulin (Equine) Product Picture
Figure 2. Global Rabies Immune Globulin (Equine) Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Rabies Immune Globulin (Equine) Market Size 2024-2034 (US$ Million)
Figure 4. Global Rabies Immune Globulin (Equine) Sales 2024-2034 (K Units)
Figure 5. United States Rabies Immune Globulin (Equine) Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 6. United States Rabies Immune Globulin (Equine) Market Size 2024-2034 (US$ Million)
Figure 7. United States Rabies Immune Globulin (Equine) Sales 2024-2034 (K Units)
Figure 8. United States Rabies Immune Globulin (Equine) Market Share in Global, in Value (US$ Million) 2024-2034
Figure 9. United States Rabies Immune Globulin (Equine) Market Share in Global, in Volume (K Units) 2024-2034
Figure 10. Rabies Immune Globulin (Equine) Report Years Considered
Figure 11. Product Picture of 1500IU
Figure 12. Product Picture of 1000IU
Figure 13. Product Picture of 400IU
Figure 14. Product Picture of Others
Figure 15. Global Rabies Immune Globulin (Equine) Market Share by Type in 2022 & 2034
Figure 16. Global Rabies Immune Globulin (Equine) Sales in Value by Type (2024-2034) & (US$ Million)
Figure 17. Global Rabies Immune Globulin (Equine) Sales Market Share in Value by Type (2024-2034)
Figure 18. Global Rabies Immune Globulin (Equine) Sales by Type (2024-2034) & (K Units)
Figure 19. Global Rabies Immune Globulin (Equine) Sales Market Share in Volume by Type (2024-2034)
Figure 20. Global Rabies Immune Globulin (Equine) Price by Type (2024-2034) & (US$/Unit)
Figure 21. United States Rabies Immune Globulin (Equine) Market Share by Type in 2022 & 2034
Figure 22. United States Rabies Immune Globulin (Equine) Sales in Value by Type (2024-2034) & (US$ Million)
Figure 23. United States Rabies Immune Globulin (Equine) Sales Market Share in Value by Type (2024-2034)
Figure 24. United States Rabies Immune Globulin (Equine) Sales by Type (2024-2034) & (K Units)
Figure 25. United States Rabies Immune Globulin (Equine) Sales Market Share in Volume by Type (2024-2034)
Figure 26. United States Rabies Immune Globulin (Equine) Price by Type (2024-2034) & (US$/Unit)
Figure 27. Product Picture of Clinic
Figure 28. Product Picture of Hospital
Figure 29. Global Rabies Immune Globulin (Equine) Market Share by Application in 2022 & 2034
Figure 30. Global Rabies Immune Globulin (Equine) Sales in Value by Application (2024-2034) & (US$ Million)
Figure 31. Global Rabies Immune Globulin (Equine) Sales Market Share in Value by Application (2024-2034)
Figure 32. Global Rabies Immune Globulin (Equine) Sales by Application (2024-2034) & (K Units)
Figure 33. Global Rabies Immune Globulin (Equine) Sales Market Share in Volume by Application (2024-2034)
Figure 34. Global Rabies Immune Globulin (Equine) Price by Application (2024-2034) & (US$/Unit)
Figure 35. United States Rabies Immune Globulin (Equine) Market Share by Application in 2022 & 2034
Figure 36. United States Rabies Immune Globulin (Equine) Sales in Value by Application (2024-2034) & (US$ Million)
Figure 37. United States Rabies Immune Globulin (Equine) Sales Market Share in Value by Application (2024-2034)
Figure 38. United States Rabies Immune Globulin (Equine) Sales by Application (2024-2034) & (K Units)
Figure 39. United States Rabies Immune Globulin (Equine) Sales Market Share in Volume by Application (2024-2034)
Figure 40. United States Rabies Immune Globulin (Equine) Price by Application (2024-2034) & (US$/Unit)
Figure 41. Americas Rabies Immune Globulin (Equine) Sales in Volume Growth Rate 2024-2034 (K Units)
Figure 42. Americas Rabies Immune Globulin (Equine) Sales in Value Growth Rate 2024-2034 (US$ Million)
Figure 43. Americas Rabies Immune Globulin (Equine) Sales by Type (2024-2034) & (K Units)
Figure 44. Americas Rabies Immune Globulin (Equine) Sales Market Share in Volume by Type (2024-2034)
Figure 45. Americas Rabies Immune Globulin (Equine) Sales by Application (2024-2034) & (K Units)
Figure 46. Americas Rabies Immune Globulin (Equine) Sales Market Share in Volume by Application (2024-2034)
Figure 47. United States Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 48. Canada Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 49. Mexico Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 50. Brazil Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 51. EMEA Rabies Immune Globulin (Equine) Sales in Volume Growth Rate 2024-2034 (K Units)
Figure 52. EMEA Rabies Immune Globulin (Equine) Sales in Value Growth Rate 2024-2034 (US$ Million)
Figure 53. EMEA Rabies Immune Globulin (Equine) Sales by Type (2024-2034) & (K Units)
Figure 54. EMEA Rabies Immune Globulin (Equine) Sales Market Share in Volume by Type (2024-2034)
Figure 55. EMEA Rabies Immune Globulin (Equine) Sales by Application (2024-2034) & (K Units)
Figure 56. EMEA Rabies Immune Globulin (Equine) Sales Market Share in Volume by Application (2024-2034)
Figure 57. Europe Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 58. Middle East Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 59. Africa Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 60. China Rabies Immune Globulin (Equine) Sales in Volume Growth Rate 2024-2034 (K Units)
Figure 61. China Rabies Immune Globulin (Equine) Sales in Value Growth Rate 2024-2034 (US$ Million)
Figure 62. China Rabies Immune Globulin (Equine) Sales by Type (2024-2034) & (K Units)
Figure 63. China Rabies Immune Globulin (Equine) Sales Market Share in Volume by Type (2024-2034)
Figure 64. China Rabies Immune Globulin (Equine) Sales by Application (2024-2034) & (K Units)
Figure 65. China Rabies Immune Globulin (Equine) Sales Market Share in Volume by Application (2024-2034)
Figure 66. APAC Rabies Immune Globulin (Equine) Sales in Volume Growth Rate 2024-2034 (K Units)
Figure 67. APAC Rabies Immune Globulin (Equine) Sales in Value Growth Rate 2024-2034 (US$ Million)
Figure 68. APAC Rabies Immune Globulin (Equine) Sales by Type (2024-2034) & (K Units)
Figure 69. APAC Rabies Immune Globulin (Equine) Sales Market Share in Volume by Type (2024-2034)
Figure 70. APAC Rabies Immune Globulin (Equine) Sales by Application (2024-2034) & (K Units)
Figure 71. APAC Rabies Immune Globulin (Equine) Sales Market Share in Volume by Application (2024-2034)
Figure 72. Japan Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 73. South Korea Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 74. China Taiwan Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 75. Southeast Asia Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 76. India Rabies Immune Globulin (Equine) Sales in Value Growth Rate (2024-2034) & (US$ Million)
Figure 77. Rabies Immune Globulin (Equine) Value Chain
Figure 78. Rabies Immune Globulin (Equine) Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed